Selected research
Industry Research
Personalized Precision Medicine Industry Research Report 2026
Market perspective
The global Personalized Precision Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Personalized Precision Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Personalized Precision Medicine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Personalized Precision Medicine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Personalized Precision Medicine include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca and Sanofi, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Personalized Precision Medicine market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Personalized Precision Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Personalized Precision Medicine Market by Company
Agilent Technologies
Biogen
Johnson & Johnson
Boai NKY Pharmaceuticals Ltd.
Novartis
Pfizer
Roche
AstraZeneca
Sanofi
Amgen
Takeda Pharmaceutical
Merck
Eli Lilly
IQVIA
AbbVie
Parexel
Personalized Precision Medicine Segment by Type
Gene Therapy
Personalized Medication
Health Management
Others
Personalized Precision Medicine Segment by Application
Tumors and Cancer
Cardiovascular Diseases
Genetic Disease
Autoimmune Disease
Others
Personalized Precision Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personalized Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Personalized Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Therapy
- Personalized Medication
- Health Management
- Others
Applications
- Tumors and Cancer
- Cardiovascular Diseases
- Genetic Disease
- Autoimmune Disease
- Others
Companies covered
- Agilent Technologies
- Biogen
- Johnson & Johnson
- Boai NKY Pharmaceuticals Ltd.
- Novartis
- Pfizer
- Roche
- AstraZeneca
- Sanofi
- Amgen
- Takeda Pharmaceutical
- Merck
- Eli Lilly
- IQVIA
- AbbVie
- Parexel
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Personalized Precision Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Therapy
- 2.2.3 Personalized Medication
- 2.2.4 Health Management
- 2.2.5 Others
- 2.3 Personalized Precision Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Tumors and Cancer
- 2.3.3 Cardiovascular Diseases
- 2.3.4 Genetic Disease
- 2.3.5 Autoimmune Disease
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Personalized Precision Medicine Breakdown Data by Type
- 3.1 Global Personalized Precision Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Personalized Precision Medicine Forecasted Market Size by Type (2027-2032)
4 Personalized Precision Medicine Breakdown Data by Application
- 4.1 Global Personalized Precision Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Personalized Precision Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Personalized Precision Medicine Market Perspective (2021-2032)
- 5.2 Global Personalized Precision Medicine Growth Trends by Region
- 5.2.1 Global Personalized Precision Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Personalized Precision Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Personalized Precision Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Personalized Precision Medicine Market Dynamics
- 5.3.1 Personalized Precision Medicine Industry Trends
- 5.3.2 Personalized Precision Medicine Market Drivers
- 5.3.3 Personalized Precision Medicine Market Challenges
- 5.3.4 Personalized Precision Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Personalized Precision Medicine Players by Revenue
- 6.1.1 Global Top Personalized Precision Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Personalized Precision Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Personalized Precision Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Personalized Precision Medicine Head Office and Area Served
- 6.4 Global Personalized Precision Medicine Players, Product Type & Application
- 6.5 Global Personalized Precision Medicine Manufacturers Established Date
- 6.6 Global Personalized Precision Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Personalized Precision Medicine Market Size (2021-2032)
- 7.2 North America Personalized Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Personalized Precision Medicine Market Size by Country (2021-2026)
- 7.4 North America Personalized Precision Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Personalized Precision Medicine Market Size (2021-2032)
- 8.2 Europe Personalized Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Personalized Precision Medicine Market Size by Country (2021-2026)
- 8.4 Europe Personalized Precision Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Personalized Precision Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Personalized Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Personalized Precision Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Personalized Precision Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Personalized Precision Medicine Market Size (2021-2032)
- 10.2 South America Personalized Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Personalized Precision Medicine Market Size by Country (2021-2026)
- 10.4 South America Personalized Precision Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Personalized Precision Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Personalized Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Personalized Precision Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Personalized Precision Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Agilent Technologies
- 12.1.1 Agilent Technologies Company Information
- 12.1.2 Agilent Technologies Business Overview
- 12.1.3 Agilent Technologies Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.1.4 Agilent Technologies Personalized Precision Medicine Product Portfolio
- 12.1.5 Agilent Technologies Recent Developments
- 12.2 Biogen
- 12.2.1 Biogen Company Information
- 12.2.2 Biogen Business Overview
- 12.2.3 Biogen Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.2.4 Biogen Personalized Precision Medicine Product Portfolio
- 12.2.5 Biogen Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.3.4 Johnson & Johnson Personalized Precision Medicine Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Boai NKY Pharmaceuticals Ltd.
- 12.4.1 Boai NKY Pharmaceuticals Ltd. Company Information
- 12.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
- 12.4.3 Boai NKY Pharmaceuticals Ltd. Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio
- 12.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments
- 12.5 Novartis
- 12.5.1 Novartis Company Information
- 12.5.2 Novartis Business Overview
- 12.5.3 Novartis Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.5.4 Novartis Personalized Precision Medicine Product Portfolio
- 12.5.5 Novartis Recent Developments
- 12.6 Pfizer
- 12.6.1 Pfizer Company Information
- 12.6.2 Pfizer Business Overview
- 12.6.3 Pfizer Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.6.4 Pfizer Personalized Precision Medicine Product Portfolio
- 12.6.5 Pfizer Recent Developments
- 12.7 Roche
- 12.7.1 Roche Company Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.7.4 Roche Personalized Precision Medicine Product Portfolio
- 12.7.5 Roche Recent Developments
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Information
- 12.8.2 AstraZeneca Business Overview
- 12.8.3 AstraZeneca Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.8.4 AstraZeneca Personalized Precision Medicine Product Portfolio
- 12.8.5 AstraZeneca Recent Developments
- 12.9 Sanofi
- 12.9.1 Sanofi Company Information
- 12.9.2 Sanofi Business Overview
- 12.9.3 Sanofi Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.9.4 Sanofi Personalized Precision Medicine Product Portfolio
- 12.9.5 Sanofi Recent Developments
- 12.10 Amgen
- 12.10.1 Amgen Company Information
- 12.10.2 Amgen Business Overview
- 12.10.3 Amgen Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.10.4 Amgen Personalized Precision Medicine Product Portfolio
- 12.10.5 Amgen Recent Developments
- 12.11 Takeda Pharmaceutical
- 12.11.1 Takeda Pharmaceutical Company Information
- 12.11.2 Takeda Pharmaceutical Business Overview
- 12.11.3 Takeda Pharmaceutical Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.11.4 Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio
- 12.11.5 Takeda Pharmaceutical Recent Developments
- 12.12 Merck
- 12.12.1 Merck Company Information
- 12.12.2 Merck Business Overview
- 12.12.3 Merck Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.12.4 Merck Personalized Precision Medicine Product Portfolio
- 12.12.5 Merck Recent Developments
- 12.13 Eli Lilly
- 12.13.1 Eli Lilly Company Information
- 12.13.2 Eli Lilly Business Overview
- 12.13.3 Eli Lilly Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.13.4 Eli Lilly Personalized Precision Medicine Product Portfolio
- 12.13.5 Eli Lilly Recent Developments
- 12.14 IQVIA
- 12.14.1 IQVIA Company Information
- 12.14.2 IQVIA Business Overview
- 12.14.3 IQVIA Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.14.4 IQVIA Personalized Precision Medicine Product Portfolio
- 12.14.5 IQVIA Recent Developments
- 12.15 AbbVie
- 12.15.1 AbbVie Company Information
- 12.15.2 AbbVie Business Overview
- 12.15.3 AbbVie Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.15.4 AbbVie Personalized Precision Medicine Product Portfolio
- 12.15.5 AbbVie Recent Developments
- 12.16 Parexel
- 12.16.1 Parexel Company Information
- 12.16.2 Parexel Business Overview
- 12.16.3 Parexel Revenue in Personalized Precision Medicine Business (2021-2026)
- 12.16.4 Parexel Personalized Precision Medicine Product Portfolio
- 12.16.5 Parexel Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst